PaO2/FiO2 ratio and NT-proBNP were assessed at baseline, 24 hours, 3 days, and 7 days, while mPAP was measured at baseline, 24 hours, and 7 days. Safety endpoints included mortality, hemodynamic ...
Background In critically ill patients the PaO2/FIO2 ratio is an indicator of oxygenation status and is one of the diagnostic criteria for acute respiratory distress syndrome in adults (ARDS) [1 - 4].
The ratio between arterial blood partial pressure of oxygen and fraction of inspired oxygen (PaO2/FiO2) was largely used for grading and managing the respiratory failure in non-mechanically ventilated ...
Objectives COVID-19 causes lung parenchymal and endothelial damage that lead to hypoxic acute respiratory failure (hARF). The influence of hARF severity on patients’ outcomes is still poorly ...
MPR, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results